U.S. market Closed. Opens in 1 hour 27 minutes

PRGO | Perrigo Company plc Stock Overview

(Stock Exchange: NYSE)
Day's Range 26.80 - 27.30
52 Week Range 23.89 - 34.60
Beta 0.47
Implied Volatility 37.69%
IV Rank 31.05%
Day's Volume 1,035,770
Average Volume 1,444,378
Shares Outstanding 136,428,000
Market Cap 3,704,020,200
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
IPO Date 1991-12-17
Valuation
Profitability
Growth
Health
P/E Ratio -25.37
Forward P/E Ratio N/A
EPS -1.07
1YR Price Target N/A
Dividend Yield 4.05%
Dividend Per Share 1.10
Dividend ExDate N/A
Dividend PayDate N/A
Employees 9,140
Country Ireland
Website PRGO
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
PRGO's peers: KMDA, PBH, AMPH, DCPH, PCRX, COLL, PAHC, ELAN, RDY, SSIC, EGRX, ANIP
*Chart delayed
Analyzing fundamentals for PRGO we got that it has weak fundamentals where Valuation is considered to be slightly undervalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see PRGO Fundamentals page.

Watching at PRGO technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on PRGO Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙